Test filters

News

In the media

Press releases

Publications

Scientific articles

Statements

Stories

Videos

Viewpoints

Scientific articles

27 Mar 2026

Prognostic models predicting clinical outcomes in patients diagnosed with visceral leishmaniasis: a systematic review

BMJ Public Health

News

31 Mar 2026

DNDi is looking for a Board Treasurer to join its Board of Directors

In the media

26 Mar 2026

Boron plays a key role in new sleeping sickness drug

Chemistry World

Videos

26 Mar 2026

Manufacturing medicines for NTDs, with Dr Stephen Robinson

Scientific articles

14 Jan 2026

(Un)intended consequences: a social sciences stocktake of a decade of Global Action Plan-inspired antimicrobial governance

The Lancet Microbe

Scientific articles

24 Mar 2026

The burden of eumycetoma in Africa: a neglected fungal disease

The Lancet Regional Health – Africa

Statements

23 Mar 2026

DNDi statement at the sixth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement

In the media

18 Mar 2026

RD Congo : Un nouveau traitement contre la maladie du sommeil

TV5Monde

News

16 Mar 2026

A new drug could be the beginning of the end for sleeping sickness

NPR

News

16 Mar 2026

The Best Weapon Yet Against Sleeping Sickness

Science

News

16 Mar 2026

Why sleeping sickness pill is raising hopes in Africa

SciDev.Net

In the media

15 Mar 2026

Tres pastillas en una dosis única, la bala de plata contra la enfermedad del sueño

El Periódico

In the media

14 Mar 2026

Africa’s one-dose cure brings sleeping sickness elimination within reach

The Independent

In the media

12 Mar 2026

Single-dose sleeping sickness drug set for approval

Nature

In the media

12 Mar 2026

Faire des morsures de serpent une priorité de santé publique

SciDev.Net

News

12 Mar 2026

2025 R&D programmes in review: Sleeping sickness

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Prognostic models predicting clinical outcomes in patients diagnosed with visceral leishmaniasis: a systematic review

DNDi is looking for a Board Treasurer to join its Board of Directors

Boron plays a key role in new sleeping sickness drug

Manufacturing medicines for NTDs, with Dr Stephen Robinson

(Un)intended consequences: a social sciences stocktake of a decade of Global Action Plan-inspired antimicrobial governance

The burden of eumycetoma in Africa: a neglected fungal disease

DNDi statement at the sixth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement

RD Congo : Un nouveau traitement contre la maladie du sommeil

A new drug could be the beginning of the end for sleeping sickness

The Best Weapon Yet Against Sleeping Sickness

Why sleeping sickness pill is raising hopes in Africa

Tres pastillas en una dosis única, la bala de plata contra la enfermedad del sueño

Africa’s one-dose cure brings sleeping sickness elimination within reach

Single-dose sleeping sickness drug set for approval

Faire des morsures de serpent une priorité de santé publique

2025 R&D programmes in review: Sleeping sickness

Learn more

Get in touch

Support us

Work with us